Defining rewardable innovation in drug therapy
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Defining rewardable innovation in drug therapy. / Hughes, D.; Aronson, J.K.; Ferner, R.E. et al.
Yn: Nature Reviews Drug Discovery, Cyfrol 11, 01.04.2012, t. 253-254.
Yn: Nature Reviews Drug Discovery, Cyfrol 11, 01.04.2012, t. 253-254.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Aronson, JK, Ferner, RE & Hughes, DA 2012, 'Defining rewardable innovation in drug therapy', Nature Reviews Drug Discovery, cyfrol. 11, tt. 253-254. https://doi.org/10.1038/nrd3715
APA
Hughes, D., Aronson, J. K., Ferner, R. E., & Hughes, D. A. (2012). Defining rewardable innovation in drug therapy. Nature Reviews Drug Discovery, 11, 253-254. https://doi.org/10.1038/nrd3715
CBE
Hughes D, Aronson JK, Ferner RE, Hughes DA. 2012. Defining rewardable innovation in drug therapy. Nature Reviews Drug Discovery. 11:253-254. https://doi.org/10.1038/nrd3715
MLA
Hughes, D. et al. "Defining rewardable innovation in drug therapy". Nature Reviews Drug Discovery. 2012, 11. 253-254. https://doi.org/10.1038/nrd3715
VancouverVancouver
Hughes D, Aronson JK, Ferner RE, Hughes DA. Defining rewardable innovation in drug therapy. Nature Reviews Drug Discovery. 2012 Ebr 1;11:253-254. doi: 10.1038/nrd3715
Author
RIS
TY - JOUR
T1 - Defining rewardable innovation in drug therapy
AU - Hughes, D.
AU - Aronson, J.K.
AU - Ferner, R.E.
AU - Hughes, D.A.
PY - 2012/4/1
Y1 - 2012/4/1
U2 - 10.1038/nrd3715
DO - 10.1038/nrd3715
M3 - Article
VL - 11
SP - 253
EP - 254
JO - Nature Reviews Drug Discovery
JF - Nature Reviews Drug Discovery
SN - 1474-1776
ER -